Dr. Chirag Patil, MD
Claim this profileCedars-Sinai Medical Center
Area of expertise
Glioblastoma
Chirag Patil, MD has run 5 trials for Glioblastoma. Some of their research focus areas include:
Brain Tumor
Chirag Patil, MD has run 4 trials for Brain Tumor. Some of their research focus areas include:
Affiliated Hospitals
Cedars-Sinai Medical Center
Clinical Trials Chirag Patil, MD is currently running
Keto Diet vs Standard Cancer Diet
for Glioblastoma
This is a Phase 2, randomized two-armed, multi-site study of 170 patients with newly diagnosed glioblastoma multiforme. Patients will be randomized 1:1 to receive Keto Diet, or Standard Anti-Cancer Diet. All patients will receive standard of care treatment for their glioblastoma. The Keto Diet intervention will be for an 18-week period and conducted by trained research dietitians. Daily ketone and glucose levels will be recorded to monitor Keto Diet adherence. This two-armed randomized multi-site study aims to provide evidence to support the hypothesis that a Keto Diet vs. Standard Anti-Cancer Diet improves overall survival in newly diagnosed glioblastoma multiforme patients who receive standard of care treatment.
Recruiting
0 awards
Phase 2
Pembrolizumab + Stereotactic Radiation
for Glioblastoma
The purpose of this study is to assess the safety/tolerability/feasibility of pembrolizumab and radiation therapy before surgical resection in patients with recurrent glioblastoma as defined by treatment-related AEs and the number of patients who do not necessitate a delay in surgical resection, and to assess overall survival. The secondary objectives are to assess progression free survival, and to assess the T cell clonality, CD8 T cell activation and Tumor Infiltrating Lymphocyte (TIL) score after treatment
Recruiting
1 award
Phase 1 & 2
More about Chirag Patil, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Chirag Patil, MD has experience with
- Pembrolizumab
- Stereotactic Radiation Therapy
- Surgical Resection
- Neoadjuvant Stereotactic Radiosurgery
- Neurosurgical Resection
- Canvas Imaging System
Breakdown of trials Chirag Patil, MD has run
Glioblastoma
Brain Tumor
Central Nervous System Tumor
Spinal Cord Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Chirag Patil, MD specialize in?
Chirag Patil, MD focuses on Glioblastoma and Brain Tumor. In particular, much of their work with Glioblastoma has involved HLA-A positive patients, or patients who are undergoing treatment.
Is Chirag Patil, MD currently recruiting for clinical trials?
Yes, Chirag Patil, MD is currently recruiting for 2 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Chirag Patil, MD has studied deeply?
Yes, Chirag Patil, MD has studied treatments such as Pembrolizumab, Stereotactic Radiation Therapy, Surgical Resection.
What is the best way to schedule an appointment with Chirag Patil, MD?
Apply for one of the trials that Chirag Patil, MD is conducting.
What is the office address of Chirag Patil, MD?
The office of Chirag Patil, MD is located at: Cedars-Sinai Medical Center, Los Angeles, California 90048 United States. This is the address for their practice at the Cedars-Sinai Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.